How Safe is Long-term Antiplatelet Rx After a Vascular Event?
Here is new evidence that people aged 75 and older who take aspirin-based antiplatelet treatment for secondary prevention should also take PPIs.
Does Metformin Increase Dementia Risk?
Here is evidence that metformin, especially at high doses and for long periods, is associated with increased risk for neurodegenerative diseases and dementia.
5 Top Diabetes Apps for Patients
5 diabetes apps at-a-glance that help patients better manage the disease and communicate with you.
Anticonvulsant Potiga Discontinued in June 2017
The anticonvulsant known as Potiga (ezogabine) in the US and as Trobalt (retigabine) in Europe will be discontinued by the manufacturer at the end of June. Details here.
New Insights About Accelerated Long-Term Forgetting in Epilepsy
Here’s evidence that ALF may be an important memory disorder in subgroups of patients with epilepsy.
How Common Is Sudden Unexpected Death in Epilepsy?
Here is new evidence that the incidence of SUDEP is higher than expected in boys, people with psychiatric comorbidities, and other groups. Details here.
4 Neurology Apps to Share With Your Patients
These mobile apps provide tools to record medication details and reminders, first aid instructions, step-by-step recovery guides, and other topics of concern for you and your patient.
Parkinson Disease Diagnosis: MDS Criteria
Researchers tested the accuracy of the Movement Disorder Society’s criteria for diagnosing Parkinson disease.
Impact of Music Therapy on Alzheimer Symptoms
Medications to treat dementia can improve behavioral symptoms, but have risks. Music therapy, however, offers a low-cost, nonpharmacological option.
Endovascular Therapy: Every Minute Counts
To estimate just how much treatment delays impact the effectiveness of endovascular therapy, researchers constructed a model using data from various sources.
By clicking Accept, you agree to become a member of the UBM Medica Community.